The latest FDA approval was based on the results of the ADVANCE trial, which showed that five times as many adults with mild to moderate plaque psoriasis receiving oral Otezla 30 mg twice daily ...

Topical therapies are relatively low-cost and usually the first approach in people with mild to moderate psoriasis ...

Amgen maintains that Otezla remains the only approved oral systemic therapy with a broad indication and is “well positioned” to help the 4 million US patients with mild to moderate psoriasis ...

While there are plenty of over-the-counter psoriasis treatments, you’ll probably need a prescription medication unless you have a very mild case. Psoriasis can cause red, dry, itchy skin patches ...

The usual maintenance dosage of Otezla (apremilast) is two 30-mg doses per day. It’s important to take the Otezla dosage your doctor prescribes. Otezla belongs to a class of drugs called disease ...

The American Academy of Dermatology/National Psoriasis Foundation (AAD/NPF) guidelines state that "topical medications are the most common agents used to treat patients with mild or moderate ...